Zyrop 10000 Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders, and those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of the blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood. Zyrop 10000 Injection contains Recombinant Human Erythropoietin Alfa, which works by stimulating the bone marrow to produce more red blood cells, thereby correcting low blood counts and anaemia. In some cases, Zyrop 10000 Injection may cause specific common side effects such as vomiting, diarrhoea, fever, and nasal congestion. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects consistently. Please inform the doctor of your detailed medical history, including hypertension, heart disease, heart attack, stroke, epilepsy, cancer, liver disease, thromboembolism, porphyria and/or pure red cell aplasia (where the bone marrow cannot produce enough RBCs). Consult your doctor before taking Zyrop 10000 Injection during pregnancy and nursing. Store this medicine at 2°C-8°C. Do not freeze.

Eporise 10000 Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders, and those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of the blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood. Eporise 10000 Injection contains Recombinant Human Erythropoietin Alfa, which works by stimulating the bone marrow to produce more red blood cells, thereby correcting low blood counts and anaemia. In some cases, Eporise 10000 Injection may cause specific common side effects such as vomiting, diarrhoea, fever, and nasal congestion. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects consistently. Please inform the doctor of your detailed medical history, including hypertension, heart disease, heart attack, stroke, epilepsy, cancer, liver disease, thromboembolism, porphyria and/or pure red cell aplasia (where the bone marrow cannot produce enough RBCs). Consult your doctor before taking Eporise 10000 Injection during pregnancy and nursing. Store this medicine at 2°C-8°C. Do not freeze.

Actorise 25mg Injection – Uses Active Ingredient: Darbepoetin alfa (25 mcg) Main Uses: Anemia in Chronic Kidney Disease (CKD): Actorise 25 is used to treat anemia caused by reduced erythropoietin production in patients with kidney disease. It helps increase red blood cell count, improving oxygen levels and reducing symptoms like fatigue. Anemia from Chemotherapy: In cancer patients undergoing chemotherapy, Actorise helps manage anemia resulting from the suppression of red blood cell production. How It Works: Darbepoetin alfa is a man-made version of erythropoietin, a hormone that encourages the bone marrow to make more red blood cells. This increases hemoglobin levels and improves the body's ability to carry oxygen. Administration: Given by injection under the skin (subcutaneous) or into a vein (intravenous). Should be administered by a healthcare professional. Storage Instructions: Store in a refrigerator at 2°C to 8°C. Do not freeze. Keep away from light. Precautions: Regular blood tests are needed to monitor hemoglobin levels and blood pressure. Not suitable for people with uncontrolled high blood pressure. Avoid if allergic to darbepoetin alfa or any similar medication.

Actorise 60mg Injection – Uses Active Ingredient: Darbepoetin alfa (60 mcg) Primary Uses: Anemia due to Chronic Kidney Disease (CKD): Actorise helps treat anemia in patients with CKD by stimulating the production of red blood cells. Anemia from Chemotherapy: It is also used to treat anemia in cancer patients undergoing chemotherapy, where red blood cell production is often reduced. How It Works: Actorise contains darbepoetin alfa, a lab-made version of a natural hormone called erythropoietin. It signals the bone marrow to produce more red blood cells, helping to improve oxygen levels in the body and reduce fatigue caused by anemia.

A healthy eye produces enough tears to keep it moist and healthy. However, in patients with Dry Eyes or Keratoconjunctivitis sicca (KCS), either the amount of tear production is reduced or the rate at which the tear evaporates is increased. Visioaid is Schirmer’s test strip (STT) that helps to diagnose KCS. Based on the extent to which the STT strip is moistened by tears, the veterinarian is able to diagnose the severity of KCS and provide suitable treatment. The veterinarian will place the tip of VISIOAID inside the eyelid, closes the eye, and holds the paper for exactly 60 seconds. The distance travelled by the tears on the VISIOAID strip in sixty seconds is recorded and the diagnosis is made.

Zyrop 5000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Zyrop 5000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Zyrop 5000IU injection.

DARCEPT 40MG INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). DARCEPT 40MG INJECTION helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. DARCEPT 40MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. DARCEPT 40MG INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, DARCEPT 40MG INJECTION stimulates the production of this protein in the bone marrow. DARCEPT 40MG INJECTION will be injected by the healthcare provider. Do not self-administer. The most common side effects of DARCEPT 40MG INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of DARCEPT 40MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Erypeg 100mcg Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction. Erypeg 100mcg Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective. The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.

Erypeg 50mcg Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction. Erypeg 50mcg Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective. The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.